20th November 2013: Sphere Fluidics and Professor Wilhelm Huck Publishes Paper on Single Cell Cytokine Analysis
In a collaboration with Professor Wilhelm Huck's science team (based at Radboud University, Nijmegen), Sphere Fluidics has published a paper on use of picodroplets for measurement of cytokine release from single T-cells. The tile of the paper is "Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics. The article was published in Lab on a Chip, info here:
17th November 2013: Sphere Fluidics to Attend "Advances in Recombinant Protein Technology" Conference
Sphere Fluidics will be attending the ELRIG conference "Advances in Recombinant Protein Technology 2013" on 19th-20th November. The conference covers protein expression technologies, protein engineering, synthetic biology and host cell selection. Dr Karine Enesa (Principal Scientist) will be one of the Sphere Fluidics' attendees, "Our technology is enabling for rapid screening and isolation of transfected cells, their (synthetic) pathways and novel secreted or cell surface-associated proteins. I look forward to attending the conference and discussing this with other attendees". Conference information can be found here:
15th November 2013: Sphere Fluidics to Attend "NanoBioTech 2013"
Dr David Holmes (a Principal Engineer at Sphere Fluidics Limited) will be attending the "NanoBioTech 2013" conference to be held in Montreux (Switzerland) on 18th-21st November 2013. "The conference covers interesting scientific areas pertinent to our interests at Sphere Fluidics including: single cell analysis, optics, mass spectrometry and microfluidics. I look forward to scientific discussions with other attendees". Conference information can be found here:
9th November 2013: Sphere Fluidics to Join UKTI Synthetic Biology Mission to San Francisco
Dr Rob Marchmont (Commercial Director of Sphere Fluidics) will be joining a UK Trade and Investment Mission to San Francisco (USA) between 13th-17th November 2013. A specially-selected group of UK companies will meet US firms and investors which have an interest in the synthetic biology area. "Sphere Fluidics has novel technology that can analyse millions of cells and (molecules produced by) their synthetic pathways and we would be interested to develop collaborations with leading US firms in this sector". says Dr Marchmont. Some conference information can be found here:
1st November 2013: Sphere Fluidics will Attend "BioEurope Fall 2013"
Dr Rob Marchmont (Commercial Director) and Dr David Holmes (Principal Engineer) will be attending the BioEurope Fall Conference to be held in Vienna (Austria) on November 4th-6th 2013. They will be available in the UK Pavilion and attending various pre-arranged biopartering meetings. "BioEurope is an excellent forum and I look forward to meeting with some of our current partners and developing collaborations with some new firms.", said Dr Marchmont. Conference information can be found here:
28th October 2013: Sphere Fluidics to Attend "PEGS Europe Summit"
Sphere Fluidics will be attending the "PEGS Europe Protein and Antibody Engineering Summit" to be held in Lisbon (Portugal) on 4th-8th November 2013. The conference has various sessions on: Antibody Engineering, Cancer Biotherapeutics, Development of Novel Biotherapeutics and Protein Engineering. Dr Frank F. Craig (CEO) said, "This should be a superb conference for Sphere Fluidics as we are developing single cell technology that enables unique science and discoveries in these sectors". Conference information can be found here:
26th October 2013: Sphere Fluidics to Exhibit at the Royal Society's "Labs to Riches" Event
Sphere Fluidics will be attending and exhibiting at a forthcoming "Labs to Riches" event to be held in London on October 31st 2013. This annual event is organised by the Royal Society. It involves not only an exhibition of the Royal Society Enterprise Fund's portfolio companies but brings together Royal Society Fellows, business leaders and investors for an Annual Awards dinner. "We look forward to presenting to such an exclusive audience and meeting with the UK's science and business leaders", said Dr Frank F. Craig (CEO). Some more information can be found here:
21st October: Sphere Fluidics to Attend "MicroTAS 2013"
Dr Rob Marchmont (Commercial Director) and Dr Xin Liu (R&D Senior Scientist) will be attending "MicroTAS 2013" on the 27th-31st of October 2013. The conference will be held in Freiburg (Germany) and is one of the world's largest conferences on microfluidics. Dr Rob Marchmont says "The conference provides an excellent overview on scientific advances in this area and I look forward to developing new alliances and meeting with our existing (now around 100) or new customers". Conference information can be found here:
17th October 2013: Sphere Fluidics to Present at Knowledge Exchange Forum
Dr Frank F. Craig (CEO of Sphere Fluidics Ltd) will be talking at a Knowledge Exchange Forum to be held at the Babraham Research Campus on 22nd October 2013. "This will be a useful forum to share ideas and meet with other companies and scientific groups on campus" he said, "I look forward to giving updates on our Single Cell Analysis technology".
4th October 2013: Sphere Fluidics' CEO discusses Leadership in a Start-Up Environment
In an interview with Reed (a global recruitment specialist), Dr Frank F. Craig (CEO) of Sphere Fluidics discusses recruitment, retention and motivation of scientists in a start-up company. Among other statements, he says" The bottom line is that, if you don't have the best people, you don't have the best company". Details on the full inteview is available in InScientific Issue 1 and on-line:
1st October 2013: Sphere Fluidics to Attend "BIA UK Bioscience Forum"
Dr Rob Marchmont (Commercial Director of Sphere Fluidics) will be attending the "BioIndustry Association UK Bioscience Forum" in London on the 10th of October 2013. "The conference agenda gives valuable insights into industry directions and has interesting seminars into biologics, a major commercial area of interest for Sphere Fluidics. I also look forward to the interactive Biopartnering meetings" he said. Conference information can be found here:
20th September: Sphere Fluidics is featured in Lab Times
Sphere Fluidics features in a 3 page article in the September issue of Lab Times. The article entitled "Droplet by Droplet" gives a overview of the Company, its history, technology and some of its personnel. More information can be found on pages 45-47 of the following journal:
4th September: Sphere Fluidics to Attend "Single Cell Analysis/Lab-On-A-Chip Conference"
Dr Rob Marchmont (Commercial Director) and Dr Karine Enesa (Principal Scientist) will be attending the combined "Single Cell Analysis and Lab-On-A-Chip" conference in San Diego on 12th-13th September 2013. "We will be promoting some of our new technology for rapid biopharmaceutical discovery and also our exciting range of chips and specialist chemicals" said Dr Marchmont. "I am looking forward to learning more about new trends in this sector and meeting with other scientists in the field", stated Dr Enesa. Conference information can be found here:
5th August: Sphere Fluidics In-Licenses Key Patent Family in area of Picodroplet Sorting
Sphere Fluidics has now in-licensed another key patent family in the area of picodroplet manipulation. The patent family contains 7 international patents with some already granted. Dr Rob Marchmont, Commercial Director, stated "We are very pleased to obtain this license. It will help us drive our business forward in the area of picodroplets and microfluidics and allows us to further target key global markets, such as single cell analysis. This patent family is also available for out-licensing for certain applications".
25th July: Sphere Fluidics Wins Acquisition International Award for "Best UK Early Stage Investment"
Sphere Fluidics has just been awarded a Business Excellence award for "Best UK Early Stage Investment" by Acquisition International. The latter publishes Corporate Finance news and has a global readership. Dr Frank F. Craig, CEO, said "We are delighted to win this prize which is awarded to those companies with the highest votes from the journal's readers". More information on Acquisition International can be found here:
14th July 2013: Sphere Fluidics Sponsors "Microdroplets in Action Symposium 2013"
Sphere Fluidics will be both sponsoring and presenting at the new "Microdroplets in Action" conference to be held in Cambridge (UK) on the 26th July, 2013. The Conference was organised by Professor Chris Abell (A co-Founder of Sphere Fluidics) and brings together international scientific experts from all over the world. More information on the Symposium can be found here:
8th July 2013: Sphere Fluidics Launches New Pico-Gen Chip and Pico-Break Specialist Chemical Range
Sphere Fluidics has now launched a range of 25 new polymer chips (the Pico-Gen range) for picodroplet generation and a range of a new specialist chemical (Pico-Break), which de-emulsifies picodroplet suspensions to enhance recovery of cells and other molecules. Dr Frank F. Craig, CEO, said "The launch of our novel Chips complements our range of Specialist Chemicals products and makes it easier for academic and industrial scientists to use picodroplets for their research and develpoment on single cells and molecules". The chip range will be distributed and sold via the Dolomite Centre. See here for chip ordering info:
29th June 2013: Sphere Fluidics Files two new (US and GB) Patents
Sphere Fluidics has filed two new patents, one a national filing in the US and the other a new UK filing, on picodroplet technology. "We now have 8 patent families comprising 40 international patents (21 of which are granted)" said Dr Frank F. Craig (CEO). "We have a world-class portfolio and freedom-to-operate in our chosen Fields. This represents a superb asset for both us and our commercial partners".
27th June 2013: Sphere Fluidics Nominated as a Finalist in the 2013 UK Business Angels Association (UKBAA) Awards
Sphere Fluidics has been nominated as a finalist in two separate UKBAA awards categories: i) Best Early Stage Investment in a Disruptive Technology Business, and ii) Angel-VC Deal of the Year. Dr Frank F. Craig (CEO) said "It is great that the UKBAA has recognised Sphere Fluidics and our investors as being one of the best teams in the UK." The Awards Ceremony will be held in London on the 2nd of July. More information can be found here:
10th June 2013: Sphere Fluidics Relocates to New Larger Facility at Babraham Research Campus
Sphere Fluidics has now relocated to its new integrated lab and office space at the Jonas Webb Building on Babraham Research Campus. The new building was officially opened today by Rt Hon David Willetts MP (Minister for Universities and Science) who also met with Dr Frank F. Craig (CEO of Sphere Fluidics) who said “We are very pleased to move to such an excellent facility which we have designed to be “state-of-the-art”. This is all part of our plans to enable growth of our business and to accommodate the recruitment of new staff”.
6th June 2013: Dr Rob Marchmont joins Sphere Fluidics as their new Commercial Director
Dr Rob Marchmont, who previously held Senior commercial positions at NanoInk and GE Healthcare and has more than 25 years' experience in the Life Sciences market, has now joined Sphere Fluidics, to help further grow the business, as their new Commercial Director. Dr Marchmont says "I am thrilled to be joining the Sphere Fluidics team and look forward to building the business based on the success already gained and developing new markets for single cell analysis technology". Dr Frank F. Craig, CEO, said "Rob is a great addition to our team and I look forward to working with him as we accelerate growth of our business".
5th June 2013: Sphere Fluidics' Scientific Founders win European ACES Entrepreneurial Prize for Best University Life Sciences Spin-Out
Professors Chris Abell and Wilhelm Huck of Cambridge University and Radboud University, Nijmegen respectively were awarded an international prize for their enterprise in creating and developing Sphere Fluidics. Dr Andrew Mackintosh, the Chairman of Sphere Fluidics, collected the prize on the Founder's behalf in a prize-giving ceremony in Brussels. "Chris and Wilhelm are a superb example of world-class scientists who are also entrepreneurial and help commercialise their technology in exciting new spin-outs". More information on the award can be found here:
3rd June 2013: Sphere Fluidics to attend "Empowered Antibodies Congress"
Dr Xin Li (Group Leader, Chemistry) of Sphere Fluidics will be attending the "Empowered Antibodies Congress" to be held in Barcelona on June 11th–13th, 2013. “This conference gives an excellent opportunity to learn from industry leaders about antibody discovery and new ADC technology. We also believe that our Cyto-Mine technology for single cell analysis may be of interest to enable novel immunology studies with libraries of cells or nascent biotherapeutics. More conference information can be found here:
2nd June 2013: Sphere Fluidics to Attend "Forum Labo Biotech" Conference
Dr Frank F. Craig, CEO of Sphere Fluidics Limited, will be attending the "Forum Labo Biotech" Conference to be held in Paris (France) on 4th–7th of June, 2013. “The French Life Sciences market is one of the biggest in Europe. Forum Labo is an excellent, biannual conference where we can meet with potential customers and alliance partners and also view new products emerging on the market”, says Dr Craig. More information on the conference can be found here:
21st April 2013: Sphere Fluidics will be exhibiting at BIO2013
Sphere Fluidics will be attending and exhibiting at the UK Pavilion at Bio2013 in Chicago on 22nd-25th April, 2013. “Bio2013 is always enjoyable as we can combine biopartnering as well as meeting some new customers at our booth. This year we will be launching some new products at the show as well as promoting the Company’s activity via advertising in BioTech Daily”, said Dr Frank F. Craig (Sphere Fluidics’ CEO). Conference information can be found here:
9th April 2013: Sphere Fluidics co-authors on Pioneering Paper on High-Throughput, Mass Spectrometry in Analytical Chemistry
Drs Clive Smith and Xin Li (Principal Scientists at Sphere Fluidics Limited) were co-authors on a pioneering paper on the use of picodroplets for high-throughput mass spectrometry of protein libraries. The work was done in collaboration with Pfizer and Professors Chris Abell and Wilhelm Huck of the University of Cambridge and Radboud University, Nijmegen respectively. The paper is entitled "Sensitive, high throughput detection of proteins in individual, surfactant-stabilised picoliter droplets using nanoelectrospray ionization mass spectrometry". The paper was published online on March 20th, 2013 and an abstract can be viewed here:
14th March 2013: Sphere Fluidics to Attend "Ideas to Reality" Conference
Dr Frank F. Craig (CEO) will be attending a conference called "Ideas to Reality" organised by Cambridge Enterprise on March 26th 2013. This event brings together academic scientists, entrepreneurs, Cambridge Enterprise portfolio companies and potential investors. Sphere Fluidics will also be exhibiting. Dr Craig said "These events are an enjoyable celebration of innovation and entrepreneurialism".
9th March 2013: Sphere Fluidics to Attend ELRIG Conference on "Research and Innovation"
Dr Frank F. Craig (CEO) will be attending an ELRIG conference in Telford (UK) on 19th March 2013. "The scientific areas discussed at the conference include: Cellular Toxicology in Drug Discovery, Innovation in Cell Culture and Probes for Biological Systems. Sphere Fluidics' technology has novel applications in cell biology including ultra-highthroughput, clonal analysis and novel single cell-based assays. Hence, we are looking forward to contributing to the meeting". Conference information can be found here:
2nd March 2013: Sphere Fluidics to Attend the "4th Microfluidics Consortium"
Dr Clive Smith (Principal Scientist) will be attending the CfBI "4th Microfluidics Consortium" meeting in Cambridge (UK) on 15th March 2013. "This is a useful forum to learn about new innovations and science in the microfluidics area" he says. More conference information can be found here:
25th February 2013: Sphere Fluidics to Attend University of Cambridge Enterprise Fund Spring Reception
The CEO of Sphere Fluidics (Dr Frank F. Craig) will be attending, and exhibiting at, a Spring Reception organised for the portfolio companies, investors and potential investors in the new University of Cambridge Enterprise Fund (UCEF). The latter fund is the only University SEIS/EIS Fund to co-invest in University spin-outs. The reception will be held in Cambridge (UK) on the 7th of March 2013. Dr Craig comments "The UCEF is an investor in Sphere Fluidics and we will be very pleased to participate in this exciting event and meet and talk with some of our investors".
19th February 2013: Sphere Fluidics Successfully Closes a £1.6 Million Investment Round
Sphere Fluidics, an early-stage, Cambridge-based company focusing on developing novel products and services for single cell analysis, has just completed a £1.6 million investment round. The investment syndicate was led by 24Haymarket and included the Royal Society, Cambridge Enterprise Limited, Providence Investment Company Limited, University of Cambridge Enterprise Fund, the London Business Angels Roundtable EIS Fund and a number of individual angels from London (including members of the London Business Angels) and Cambridge. Frank Craig, Sphere Fluidics’ CEO, comments, “We are very pleased to close this round as it gives us the resources to further develop our business. There was strong interest in the company and we were pleased to welcome 24Haymarket into an impressive syndicate of investors. I am excited about further applying our exciting technology to major Life Sciences markets and accelerating its commercialisation”.
16th February 2013: Sphere Fluidics Attending "Single Cell Analysis" Conference
Dr Frank F. Craig (CEO) and Dr Xin Liu (Senior Scientist) will be attending a Single Cell Analysis Europe" conference in Barcelona (Spain) on 5th-6th of March 2013. Sphere Fluidics will be both attending the technical talks and promoting its new services and products at the conference. Dr Craig says "This is an excellent conference with an impressive list of international attendees. It is also a sign that this area is now becoming of significant importance to the scientific community". More conference information can be found here:
18th Jan, 2013: Sphere Fluidics Files 2 New US and 1 EP Patents
Sphere has filed several new patents on novel microfluidic chip designs for sorting of picodroplets and their analysis by mass spectrometry. Dr Frank F. Craig, the CEO, said "We are very excited about our emerging science base, in particular, the mass spectrometry area in which we are world leaders. We will also be publishing a key scientific paper in this area very shortly. We now have an impressive patent portfolio of 38 patents (with 21 being granted) representing a powerful commercial asset".